Compounded vs Branded GLP-1: What's Actually Different

"Compounded" is one of the most misunderstood words in weight loss medicine. It does not mean generic, it does not mean counterfeit, and it does not mean identical-but-cheaper. Here is what the word actually describes, and the four differences worth understanding before you talk to a provider.

1. Regulatory Status: Approved vs Not Approved

This is the difference everything else follows from. An FDA-approved drug has been through clinical trials the agency reviewed, and the FDA has evaluated its safety, its effectiveness for a specific use, and the consistency of how it is manufactured. Semaglutide is approved as Wegovy and Ozempic; tirzepatide is approved as Zepbound and Mounjaro.

A compounded preparation has not been through any of that. The FDA does not review compounded drugs for safety, effectiveness, or manufacturing quality. Compounded medications are also, importantly, not generics. A generic drug is an FDA-approved product proven equivalent to a brand-name one; no generic semaglutide or tirzepatide exists in the U.S. Any provider telling you a compounded product is "the same as" or "a generic version of" a branded GLP-1 is misrepresenting it.

2. Who Makes It

Branded GLP-1s are made by their original manufacturers — Novo Nordisk and Eli Lilly — in facilities the FDA inspects, with every batch produced to the same registered specification.

Compounded preparations are made by licensed U.S. compounding pharmacies. These are real, regulated entities: state boards of pharmacy license them, and larger outsourcing facilities register with the FDA under section 503B of the Federal Food, Drug, and Cosmetic Act. But oversight sits at the pharmacy level rather than the product level, which means the specific pharmacy's practices matter a great deal. It is a fair question to ask any telehealth provider which pharmacy fills their prescriptions and how it is licensed — and part of what to check when you evaluate an online provider.

3. How the Prescribing Decision Gets Made

Both require a prescription from a provider licensed in your state. Neither is available without one, and any site offering either without a consultation is operating outside the law.

What differs is the reasoning. Compounding is meant to address a specific patient need that a commercially available approved product does not meet — a documented intolerance to an ingredient, a dosing requirement an approved presentation cannot accommodate, or a clinically relevant supply problem. A provider is deciding whether a compounded preparation is appropriate for you, and for many patients the answer is that an FDA-approved product is the better choice. Some people should not take a GLP-1 at all, including anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or who is pregnant or planning pregnancy. Our eligibility guide covers how that screening works.

This decision belongs to a clinician assessing your history. It is not a decision a website should make for you, and it is not a decision that should turn on what something costs.

4. What the Evidence Does and Doesn't Cover

The published trial data people cite for GLP-1 weight loss — the STEP program for semaglutide, SURMOUNT for tirzepatide — studied the FDA-approved products, at defined doses, under trial conditions. Those results describe the approved drugs that were studied. They are not evidence about any particular compounded preparation, and it would be wrong to present them as such.

The side effect profile of the drug class does apply broadly: nausea, vomiting, diarrhea and constipation are the most commonly reported effects, and they are usually managed by titrating the dose gradually. What you don't get with a compounded product is the manufacturing verification that comes with FDA approval — which is precisely why ongoing provider oversight matters, and why planning for what happens after you stop should be part of the conversation from the start.

The Honest Bottom Line

A compounded GLP-1 is a legitimate category of medication prepared by licensed pharmacies under a prescription — and it is also a less verified product than an FDA-approved one. Both things are true, and a provider who tells you only one of them is not giving you the full picture. Ask what pharmacy is used, ask why a compounded preparation is being considered for you specifically, and expect a clinical answer.

Frequently Asked Questions

This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. Lito is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved and are not substitutes for FDA-approved products. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Lito is not affiliated with Novo Nordisk or Eli Lilly.